Have a personal or library account? Click to login
A brief overview of clinical significance of blood group antibodies Cover

A brief overview of clinical significance of blood group antibodies

Paid access
|Oct 2019

References

  1. Storry JR, Castilho L, Chen Q, et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and terminology: report of the Seoul and London meetings. Vox Sang 2016;11:118–22.10.1111/voxs.12280566201029093749
  2. Daniels G, Poole J, de Silva M, Callaghan T, MacLennan S, Smith N. The clinical significance of blood group antibodies. Transfus Med 2002;12:287–95.10.1046/j.1365-3148.2002.00399.x12383334
  3. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007;21:58–71.10.1016/j.tmrv.2006.08.00317174221
  4. Hendrickson JE, Tormey CA. Red blood cell antibodies in hematology/oncology patients: interpretation of immunohematologic tests and clinical significance of detected antibodies. Hematol Oncol Clin North Am 2016;30:635–51.10.1016/j.hoc.2016.01.00627113001
  5. Tormey CA, Stack G. The characterization and classification of concurrent blood group antibodies. Transfusion 2009;49:2709– 18.10.1111/j.1537-2995.2009.02337.x19682334
  6. Naik R. Warm autoimmune hemolytic anemia. Hematol Oncol Clin North Am 2015;29:445–53.10.1016/j.hoc.2015.01.00126043384
  7. Brodsky RA. Complement in hemolytic anemia. Blood 2015;126:2459–65.10.1182/blood-2015-06-64099526582375
  8. Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev 2008;22:1–15.10.1016/j.blre.2007.08.00217904258
  9. Berentsen S, Randen U, Tjonnfjord GE. Cold agglutinin-mediated autoimmune hemolytic anemia. Hematol Oncol Clin North Am 2015;29:455–71.10.1016/j.hoc.2015.01.00226043385
  10. Barcellini W. New insights in the pathogenesis of autoimmune hemolytic anemia. Transfus Med Hemother 2015;42:287–93.10.1159/000439002467832026696796
  11. Worel N. ABO-mismatched allogeneic hematopoietic stem cell transplantation. Transfus Med Hemother 2016;43:3–12.10.1159/000441507
  12. The Notify Library: the global vigilance and surveillance database for medical products of human origin. Available from www.notifylibrary.org. Accessed 15 February 2017.
  13. Klein HG, Anstee DJ. Immunology of red cells. In: Mollison’s blood transfusion in clinical medicine. 12th ed. Hoboken, NJ: John Wiley & Sons, 2014:53–117.
  14. Winters JL, Pineda AA, Gorden LD, et al. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion 2001;41:1413–20.10.1046/j.1537-2995.2001.41111413.x
  15. Delaney M, Wendel S, Bercovitz RS, et al. Transfusion reactions: prevention, diagnosis, and treatment. Lancet 2016;388:2825–36.10.1016/S0140-6736(15)01313-6
  16. U.S. Food and Drug Administration. Fatalities reported to the FDA following blood collection. 2015. Available from https://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/default.htm. Accessed 15 November 2016.
  17. The 2015 Annual SHOT Report. Available from https://www.shotuk.org/wp-content/uploads/SHOT-2015-Annual-Report-Web-Edition-Final-bookmarked.pdf. Accessed 15 November 2016.
  18. Agence nationale de sécurité du médicament et des produits de santé. Rapport d’activité hémovigilance 2015. Available from http://ansm.sante.fr/. Accessed 15 November 2016.
DOI: https://doi.org/10.21307/immunohematology-2018-002 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 4 - 6
Published on: Oct 16, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 M.J. Gandhi, D.M. Strong, B.I. Whitaker, E. Petrisli, published by American National Red Cross
This work is licensed under the Creative Commons License.